Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial

J. D.C. Ross; H. S. Cronjé; T. Paszkowski; I. Rakoczi; D. Vildaite; A. Kureishi; M. Alefelder; P. Arvis; P. Reimnitz

doi:10.1136/sti.2005.019109

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial

J. D.C. Ross^*
, H. S. Cronjé
, T. Paszkowski
, I. Rakoczi
, D. Vildaite
, A. Kureishi
, M. Alefelder
, P. Arvis
, P. Reimnitz

^*Corresponding author for this work

Whittall Street Clinic
University of The Free State
Medical University of Lublin
St. Imre Teaching Hospital
Vilnius Hospital of Emergency Care
Bayer AG
Bayer Pharma

Research output: Contribution to journal › Article › peer-review

56 Citations (SciVal)

Original language	English
Pages (from-to)	446-451
Number of pages	6
Journal	Sexually Transmitted Infections
Volume	82
Issue number	6
DOIs	https://doi.org/10.1136/sti.2005.019109
Publication status	Published (VoR) - Dec 2006

Access to Document

10.1136/sti.2005.019109

Cite this

Ross, J. D. C., Cronjé, H. S., Paszkowski, T., Rakoczi, I., Vildaite, D., Kureishi, A., Alefelder, M., Arvis, P., & Reimnitz, P. (2006). Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial. Sexually Transmitted Infections, 82(6), 446-451. https://doi.org/10.1136/sti.2005.019109

@article{d897cd4f7c97494f907a2dcfb1bcd668,

title = "Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial",

author = "Ross, \{J. D.C.\} and Cronj{\'e}, \{H. S.\} and T. Paszkowski and I. Rakoczi and D. Vildaite and A. Kureishi and M. Alefelder and P. Arvis and P. Reimnitz",

year = "2006",

month = dec,

doi = "10.1136/sti.2005.019109",

language = "English",

volume = "82",

pages = "446--451",

journal = "Sexually Transmitted Infections",

issn = "1368-4973",

publisher = "BMJ Publishing Group",

number = "6",

}

Ross, JDC, Cronjé, HS, Paszkowski, T, Rakoczi, I, Vildaite, D, Kureishi, A, Alefelder, M, Arvis, P & Reimnitz, P 2006, 'Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial', Sexually Transmitted Infections, vol. 82, no. 6, pp. 446-451. https://doi.org/10.1136/sti.2005.019109

TY - JOUR

T1 - Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease

T2 - Results of a multicentre, double blind, randomised trial

AU - Ross, J. D.C.

AU - Cronjé, H. S.

AU - Paszkowski, T.

AU - Rakoczi, I.

AU - Vildaite, D.

AU - Kureishi, A.

AU - Alefelder, M.

AU - Arvis, P.

AU - Reimnitz, P.

PY - 2006/12

Y1 - 2006/12

UR - https://www.scopus.com/pages/publications/33845876223

UR - https://www.scopus.com/pages/publications/33845876223#tab=citedBy

U2 - 10.1136/sti.2005.019109

DO - 10.1136/sti.2005.019109

M3 - Article

C2 - 16723364

AN - SCOPUS:33845876223

SN - 1368-4973

VL - 82

SP - 446

EP - 451

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

IS - 6

ER -

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial

Access to Document

Other files and links

Fingerprint

Cite this